MetaADEDB 2.0 @ LMMD
Chloral Hydrate
(RNFNDJAIBTYOQL-UHFFFAOYSA-N)
Structure
SMILES
OC(C(Cl)(Cl)Cl)O
Type(s)
Approved; Illicit; Investigational; Vet_approved
ATC code(s)
N05CC01
Molecular Formula:
C2H3Cl3O2
Molecular Weight:
165.403
Log P:
0.6673
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
302-17-0
Synonym(s)
1.
Chloral Hydrate
2.
Noctec
3.
Hydrate, Chloral
External Link(s)
MeSHD002697
PubChem Compound2707
ChEBI28142
CHEMBLCHEMBL455917
DrugBankDB01563
DrugCentral586
KEGGcpd:C06899
dr:D00265
Therapeutic Target DatabaseD02OAV
ZINC3872049
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ScreamingFAERS: 4US FAERS
2Pharmaceutical product complaintFAERS: 3US FAERS
3SomnolenceFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
5TremorFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
6AbasiaFAERS: 1OFFSIDES
US FAERS
7Cardiac ArrestFAERS: 1US FAERS
8Cold sweatFAERS: 1OFFSIDES
US FAERS
9CryingFAERS: 1US FAERS
10Drug withdrawal syndromeFAERS: 1US FAERS
11HypotensionFAERS: 1US FAERS
12Initial insomniaFAERS: 1US FAERS
13Medication ErrorFAERS: 1US FAERS
14Poor quality sleepFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Unresponsive to stimuliFAERS: 1US FAERS
16AbuseOFFSIDES
17Accidental overdoseCanada Vigilance: 1Canada Vigilance
OFFSIDES
18AgeusiaOFFSIDES
19AgitationCanada Vigilance: 3Canada Vigilance
20Alanine Aminotransferase IncreasedOFFSIDES
21Alcoholic IntoxicationOFFSIDES
22AlopeciaOFFSIDES
23Aneuploidy28087838CTD
24AngerOFFSIDES
25AnorexiaOFFSIDES
26AnosmiaOFFSIDES
27Anoxic EncephalopathyOFFSIDES
28Anticholinergic SyndromeOFFSIDES
29Antiviral drug level above therapeuticOFFSIDES
30AnxietyOFFSIDES
31Apallic syndromeOFFSIDES
32ApathyOFFSIDES
33ApneaOFFSIDES
34AstheniaOFFSIDES
35AtaxiaCanada Vigilance: 1Canada Vigilance
OFFSIDES
36Bipolar DisorderOFFSIDES
37Blood creatine phosphokinase increasedOFFSIDES
38Blood glucose abnormalOFFSIDES
39Blood glucose decreasedOFFSIDES
40Blood immunoglobulin G increasedOFFSIDES
41Blood magnesium increasedOFFSIDES
42Blood thyroid stimulating hormone increasedOFFSIDES
43Blurred visionOFFSIDES
44BronchopneumoniaOFFSIDES
45BruxismOFFSIDES
46BulimiaOFFSIDES
47Carnitine decreasedOFFSIDES
48Catheter related infectionOFFSIDES
49Cerebral atrophyOFFSIDES
50Completed SuicideCanada Vigilance: 2Canada Vigilance
OFFSIDES
51Culture positiveOFFSIDES
52DehydrationOFFSIDES
53DemyelinationOFFSIDES
54Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
55DrowsinessOFFSIDES
56Drug toxicityOFFSIDES
57Drug withdrawal headacheOFFSIDES
58DysgeusiaOFFSIDES
59Dysthymic DisorderOFFSIDES
60Eczema2525102CTD
61EpilepsyOFFSIDES
62Feeling ColdOFFSIDES
63Feeling abnormalOFFSIDES
64Flat affectOFFSIDES
65FlatulenceOFFSIDES
66Fluid overloadOFFSIDES
67FlushingCanada Vigilance: 1Canada Vigilance
68FumblingOFFSIDES
69HemiparesisOFFSIDES
70HemiplegiaOFFSIDES
71Heparin-induced thrombocytopeniaOFFSIDES
72HepatotoxicityOFFSIDES
73Immunosuppressant drug levelOFFSIDES
74Intention tremorOFFSIDES
75Kidney FailureOFFSIDES
76Klebsiella sepsisOFFSIDES
77LethargyOFFSIDES
78Leukopenia neonatalOFFSIDES
79Livedo ReticularisOFFSIDES
80Multiple SclerosisOFFSIDES
81Multiple drug overdoseOFFSIDES
82Multiple drug overdose intentionalOFFSIDES
83Musculoskeletal PainOFFSIDES
84Musculoskeletal stiffnessOFFSIDES
85Myoclonus8041377CTD
86NauseaCanada Vigilance: 1Canada Vigilance
OFFSIDES
87Neonatal Abstinence Syndrome3348657CTD
88NephrolithiasisOFFSIDES
89Nervous tensionOFFSIDES
90Neutrophil count abnormalOFFSIDES
91Oculogyric crisisOFFSIDES
92OverdoseOFFSIDES
93PainOFFSIDES
94PetechiaeCanada Vigilance: 1Canada Vigilance
95Pneumocystis jiroveci pneumoniaOFFSIDES
96PneumothoraxOFFSIDES
97PruritusCanada Vigilance: 1Canada Vigilance
98Pulmonary HypertensionOFFSIDES
99Respiratory FailureOFFSIDES
100Respiratory TherapyOFFSIDES
101Senile dementiaOFFSIDES
102Stem cell transplantOFFSIDES
103StressOFFSIDES
104StridorOFFSIDES
105Subcutaneous AbscessOFFSIDES
106TachycardiaCanada Vigilance: 1Canada Vigilance
107Transaminases increasedOFFSIDES
108Venous occlusionOFFSIDES
109Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.